NEPHROTOXICITY AND CARCINOGENIC RISK OF CISPLATIN (CDDP) PREVENTED BY SODIUM 2-MERCAPTOETHANE-SULFONATE (MESNA) - EXPERIMENTAL RESULTS

被引：12

作者：

KEMPF, SR

IVANKOVIC, S

机构：

来源：

关键词：

D O I：

10.1016/0305-7372(87)90031-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：365 / 372

页数：8

共 26 条

BROCK, N ;

POHL, J ;

STEKAR, J ;

SCHEEF, W .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (12) :1377-&

[2]

BROCK N, 1980, RECENT RES CANCER, V74, P270

[3]

BROCK N, 1982, THERAPIEWOCHE, V32, P4975

[4]

BURKERT H, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1597

[5]

CHOIE DD, 1981, LAB INVEST, V44, P397

[6]

COMIS RL, 1980, CISPLATIN CURRENT ST, P485

[7]

GONZALEZVITALE JC, 1977, CANCER, V39, P1362, DOI 10.1002/1097-0142(197704)39:4<1362::AID-CNCR2820390403>3.0.CO

[8]

2-N

[9]

HASKELL CM, 1985, CANCER TREATMENT, P88

[10]

HAYES DM, 1977, CANCER, V39, P1372, DOI 10.1002/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO